- Home
- CPHC vs ECOR Comparison
CPHC vs ECOR Comparison
Compare CPHC & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPHC | ECOR |
|---|---|---|
| Founded | 1994 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.1M | 81.0M |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CPHC | ECOR |
|---|---|---|
| Price | $15.70 | $8.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 1.2K | ★ 156.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $59,227,000.00 | $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $523.33 | ★ N/A |
| Revenue Growth | 0.14 | ★ 27.20 |
| 52 Week Low | $14.49 | $4.16 |
| 52 Week High | $21.61 | $10.37 |
Technical Indicators
Market Signals| Indicator | CPHC | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 56.62 |
| Support Level | $15.11 | $4.83 |
| Resistance Level | $16.01 | N/A |
| Average True Range (ATR) | 0.17 | 0.99 |
| MACD | -0.04 | 0.19 |
| Stochastic Oscillator | 32.15 | 63.44 |
Price Performance
Historical ComparisonAbout CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the real estate development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.